BioArctic AB (BRCTF)
13.66
+0.63
(+4.85%)
USD |
OTCM |
Nov 13, 16:00
BioArctic Price: 13.66 for Nov. 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 13.67 | 13.67 | 13.66 | 13.66 | 1000.00 |
| Nov 12, 2024 | 12.98 | 13.02 | 12.94 | 13.02 | 800.00 |
| Nov 11, 2024 | 13.19 | 13.19 | 13.19 | 13.19 | 219.00 |
| Nov 08, 2024 | 13.05 | 13.05 | 13.05 | 13.05 | 510.00 |
| Nov 07, 2024 | 13.72 | 13.72 | 13.72 | 13.72 | 0.000 |
| Nov 06, 2024 | 13.72 | 13.72 | 13.72 | 13.72 | 117.00 |
| Nov 05, 2024 | 13.37 | 13.37 | 13.37 | 13.37 | 0.000 |
| Nov 04, 2024 | 13.37 | 13.37 | 13.37 | 13.37 | 150.00 |
| Nov 01, 2024 | 14.70 | 14.70 | 14.70 | 14.70 | 0.000 |
| Oct 31, 2024 | 14.70 | 14.70 | 14.70 | 14.70 | 0.000 |
| Oct 30, 2024 | 14.70 | 14.70 | 14.70 | 14.70 | 0.000 |
| Oct 29, 2024 | 14.70 | 14.70 | 14.70 | 14.70 | 1210.00 |
| Oct 28, 2024 | 14.73 | 14.73 | 14.64 | 14.64 | 410.00 |
| Oct 25, 2024 | 14.39 | 14.39 | 14.39 | 14.39 | 0.000 |
| Oct 24, 2024 | 14.39 | 14.39 | 14.39 | 14.39 | 200.00 |
| Oct 23, 2024 | 14.92 | 14.92 | 14.92 | 14.92 | 0.000 |
| Oct 22, 2024 | 14.92 | 14.92 | 14.92 | 14.92 | 1200.00 |
| Oct 21, 2024 | 15.42 | 15.42 | 15.42 | 15.42 | 0.000 |
| Oct 18, 2024 | 15.42 | 15.42 | 15.42 | 15.42 | 0.000 |
| Oct 17, 2024 | 15.28 | 15.42 | 15.28 | 15.42 | 1140.00 |
| Oct 16, 2024 | 14.58 | 14.58 | 14.58 | 14.58 | 500.00 |
| Oct 15, 2024 | 15.20 | 15.20 | 15.20 | 15.20 | 0.000 |
| Oct 14, 2024 | 15.20 | 15.20 | 15.20 | 15.20 | 0.000 |
| Oct 11, 2024 | 15.20 | 15.20 | 15.20 | 15.20 | 0.000 |
| Oct 10, 2024 | 15.20 | 15.20 | 15.20 | 15.20 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.02
Minimum
Nov 12 2024
30.03
Maximum
Jun 16 2023
21.96
Average
21.98
Median
Feb 16 2024
Price Benchmarks
| Abliva AB | 0.01 |
| Oncopeptides AB | 0.265 |
| BioInvent International AB | 4.70 |
| Hansa Biopharma AB | 3.65 |
| Camurus AB | 56.80 |
Price Related Metrics
| PS Ratio | 43.27 |
| Price to Book Value | 13.78 |
| Earnings Yield | -0.71% |
| Market Cap | 1.206B |